Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-01-08

Clinical Trial Update: Lidocaine on Early Cognitive Dysfunction in Shoulder Arthroscopy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating lidocaine for early cognitive dysfunction after shoulder arthroscopy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lidocaine (Lidocaine)

Snippet

Sponsor: Assiut University | Conditions: Cognitive Dysfunction, Postoperative | Phase 2 | Status: UNKNOWN